Ectopic Adipose Tissue, Exercise Training & IL-6

Status Completed

Clinical Trial Summary

Aim: Exercise training improves the risk of cardiometabolic diseases; yet the underlying mechanisms are unclear. Exercise induces release of IL-6 from skeletal muscle. Acute elevations in IL-6 improve lipid and glucose metabolism, the latter partly through a delayed gastric emptying. Physical inactivity causes accumulation of visceral fat (VAT). Visceral and epicardial adipose tissue (EAT) is more inflamed than subcutaneous adipose tissue. Thus, the investigators hypothesize that exercise-induced IL-6 mediates the exercise-induced reduction in EAT and VAT. Secondly, the investigators hypothesize that exercise-induced adaptations in glucose metabolism and gastric motility are dependent on IL-6. Finally the investigators hypothesise that both endurance and resistance exercise training reduce VAT and EAT. Primary aim: To investigate the effects of exercise training on VAT and to determine to what extend IL-6 mediates this effect. Secondary aims: 1) To determine whether 12 weeks of endurance and strength training can reduce the amount of EAT. 2) To study whether the effects of exercise on glucose metabolism and gastric emptying are dependent on IL-6. Methods: Inclusion: 70 inactive men and women, >18 years, waist to height ratio > 0.5 and/or waist circumference ≥ 88 cm (women); waist circumference ≥ 102 cm (men) Design: A 12-week, double-blinded randomised, placebo-controlled exercise intervention study. Intervention: Subjects will be randomised to one of five groups: i) Tocilizumab (IL-6 receptor antibody) and endurance training, ii) Placebo to Tocilizumab and endurance training, iii) Tocilizumab, no exercise iv) Placebo to Tocilizumab and no training, and v) Placebo to Tocilizumab, and resistance training. Tocilizumab/placebo dose will be administered (according to standard recommendations) before the first training session, and maintained during the 12-week training program. Training will be supervised to ensure intensity and compliance. Subjects will be instructed not to change eating habits and informed that this study does not aim for a weight loss. Statistical considerations: Study investigators are blinded to treatment allocation. Dropouts will be replaced. A sample size of 70 subjects is needed to detect a 10% change in visceral adipose, with a power of 80% and a significance level of 0.05.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02901496
Study type	Interventional
Source	Rigshospitalet, Denmark
Contact
Status	Completed
Phase	N/A
Start date	August 2016
Completion date	April 2018

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05486338` - Endoscopic Gastric Mucosal Ablation as a Primary Obesity Therapy	N/A
Active, not recruiting	`NCT02558920` - Meta-analyses of Food Sources of Fructose-Containing Sugars and Obesity
Recruiting	`NCT04098679` - Childhood Adiposity and Neurodevelopmental Outcomes Among Offspring of Women With Type 1 Diabetes (CONCEPTT Kids)
Terminated	`NCT03631680` - The Role of Estrogen in Adipocyte Remodeling Following Surgical Menopause
Not yet recruiting	`NCT04096404` - Gene-based Personalised Diet and Physical Activity Advice on Adiposity Indices Personalised Diet and Physical Activity Advice on Adiposity Indices in University Students	N/A
Completed	`NCT02975258` - Adiposity and Airway Inflammation in HIV-Associated Airway Disease	N/A
Enrolling by invitation	`NCT01971840` - Effectiveness of a Physical Activity Intervention on Preventing Obesity During the Adiposity Rebound Period.	N/A
Completed	`NCT02151825` - Effect of a Synbiotic on the Gut Microbiota and Adiposity-related Markers in Healthy Overweight Subjects	N/A
Recruiting	`NCT05992688` - The Sweet Kids Study (Stevia on Weight and Energy Effect Over Time)	N/A
Active, not recruiting	`NCT03575897` - Serial Assessment of Body Fat Accrual in Very Preterm Infants	N/A
Completed	`NCT03642223` - Central and Peripheral Adiposity and Iron Absorption	N/A
Active, not recruiting	`NCT03542370` - Umbrella Review of the DASH Dietary Pattern and Cardiometabolic Risk
Completed	`NCT03898518` - The Effects of a Jump Rope Exercise Program on Body Composition and Self-efficacy in Obese Adolescent Girls	N/A
Recruiting	`NCT05324488` - Diabetes Registry Graz for Biomarker Research
Completed	`NCT02654535` - Meta-analyses of Nuts and Risk of Obesity
Completed	`NCT01922791` - Nutrition and Pregnancy Intervention Study	N/A
Recruiting	`NCT02041039` - REWARD SYSTEM RESPONSES TO FOOD AROMAS
Completed	`NCT03219125` - Bone Marrow Adiposity and Fragility Fractures in Postmenopausal Women
Recruiting	`NCT05433688` - Study on the Performance of Symmcora® Mid-term Suture Versus Novosyn® Suture in Patients Undergoing Robotic Assisted Gastric Bypass Surgery
Active, not recruiting	`NCT05654051` - The SLIM LIVER Study	Phase 2

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Ectopic Adipose Tissue, Exercise Training and IL-6

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms